Navigation Links
GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs
Date:5/6/2009

WASHINGTON, May 6 /PRNewswire/ -- The Generic Animal Drug Alliance (GADA), an independent professional trade organization representing generic animal health industry interests, says that the recent tragic deaths of 21 horses in Wellington, Florida illustrates the potential safety issues surrounding compounded drugs and reinforces the need for, and value of, Food and Drug Administration (FDA) approved animal generic drugs.

The polo horse deaths were reportedly caused by improperly compounded drugs. Compounded drugs are customized medications prepared by a pharmacist under prescription by a veterinarian. Considered a last resort, compounded drugs should be used only when no FDA-approved animal or human drug is available to treat the animal. Unlike generic drugs, compounded drugs are not FDA-approved and do not follow current good manufacturing practice (cGMP) requirements.

GADA has been working to help veterinarians understand the difference between compounded drugs and generic drugs. Generic drugs, widely used and trusted by veterinarians, are FDA-approved bio-equivalent versions of branded medicines, manufactured under strict regulatory guidelines. Generic drugs, as with other FDA-approved drugs, undergo rigorous testing to meet quality standards. Stephanie Batliner, GADA Chairperson, says that veterinarians face a variety of prescribing options and must be aware of the safety issues. "While generic drugs meet safety standards ensured by FDA-approval, compounded drugs have inherent risks associated with uncontrolled, extemporaneous preparation," says Batliner. GADA provides further information on their website, as well as a link to the brochure "Veterinary Compounding" co-authored by the American Veterinary Medical Association (AVMA), the Animal Health Institute (AHI), and the American Veterinary Distributors Association (AVDA), www.gadaonline.org.

About Generic Animal Drug Alliance

The Generic Animal Drug Alliance (GADA) is an independent professional trade organization that represents the interests of generic animal health companies before Federal regulatory agencies and Congress. Member companies are focused on the development, approval and marketing of high quality generic drugs for animals and pets--making the cost of care for all animals affordable for ranchers, farmers and pet owners.


'/>"/>
SOURCE The Generic Animal Drug Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Candies Foundation Appoints Bristol Palin As Teen Ambassador
2. WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
3. Shamir Optical Industry Ltd. Appoints Amos Netzer as New Chief Executive Officer
4. Protein Sciences Corporation Appoints New Board of Directors
5. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
6. Mother-daughter breast density study points way to earlier cancer risk assessment
7. PDL BioPharma Appoints Karen J. Wilson as Vice President, Finance and Principal Accounting Officer
8. Craneware Appoints New Non-Executive Director
9. BMP Sunstone Appoints Les R. Baledge to Board of Directors
10. ATS Medical Appoints New Vice President of Marketing
11. InfuSystem Appoints Bryan Russo as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... to catalyze conversations in support of bold systems change models helping to achieve ... an event on September 21, 2017, “We the Future: Accelerating Sustainable Development Solutions” ...
(Date:8/17/2017)... ... August 17, 2017 , ... SeQuel Response announced today that for ... among the fastest-growing private companies in the U.S., putting it in the top 10 ... applied to the Inc. 5000 over the years, only a fraction have ...
(Date:8/17/2017)... ... 2017 , ... Dr. Charles W. Grimsley’s new book ... 9781498497626; $7.99, eBook, 9781498497633) focuses on the treatment of veterans diagnosed with posttraumatic ... through a progressive journey toward healing. This book will help readers learn to ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC recently ... is a member of the firm’s Commercial Litigation and Employment Law groups. , Ms. ... of knowledge in matters of employment litigation, commercial litigation and business disputes. Her experience ...
(Date:8/17/2017)... ... August 17, 2017 , ... A recent report indicates that circa 79 percent ... cited deficiencies in data integrity. The FDA outlines their expectations for quality critical instrumentation ... as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... 4, 2017 The search for test results ... physician/patient consult has long been the goal of healthcare ... focus of the largest meeting of lab professionals and ... market research firm Kalorama Information.  The firm said scores ... or related supplies and software were at the American ...
Breaking Medicine Technology: